Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Reiter

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Difluoroketones as inhibitors of matrix metalloprotease-13L A Reiter, G J Martinelli, L A Reeves, et al.
Annals of the New York Academy of Sciences|September 6, 1994
Inhibition of interleukin-1-stimulated collagen degradation in cartilage explantsP G Mitchell, L Lopresti-Morrow, S A Yocum, et al.
Journal of Medicinal Chemistry|February 1, 1990
Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPaseJ L LaMattina, P A McCarthy, L A Reiter, et al.
Digestive Diseases and Sciences|December 1, 1991
CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective propertiesJ P Hakkinen, W F Holt, C J Goddard, et al.
Journal of Medicinal Chemistry|September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis modelK Koch, L S Melvin, L A Reiter, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptorL A Reiter, K Koch, A D Piscopio, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543H J Showell, M J Conklyn, R Alpert, et al.
Journal of Medicinal Chemistry|January 5, 1996
Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH groupR P Robinson, L A Reiter, W E Barth, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Difluoroketones as inhibitors of matrix metalloprotease-13L A Reiter, G J Martinelli, L A Reeves, et al.
Annals of the New York Academy of Sciences|September 6, 1994
Inhibition of interleukin-1-stimulated collagen degradation in cartilage explantsP G Mitchell, L Lopresti-Morrow, S A Yocum, et al.
Journal of Medicinal Chemistry|February 1, 1990
Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPaseJ L LaMattina, P A McCarthy, L A Reiter, et al.
Digestive Diseases and Sciences|December 1, 1991
CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective propertiesJ P Hakkinen, W F Holt, C J Goddard, et al.
Journal of Medicinal Chemistry|September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis modelK Koch, L S Melvin, L A Reiter, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptorL A Reiter, K Koch, A D Piscopio, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543H J Showell, M J Conklyn, R Alpert, et al.
Journal of Medicinal Chemistry|January 5, 1996
Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH groupR P Robinson, L A Reiter, W E Barth, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
Pageof 2